Thiruma Arumugam
Professor Arumugam completed his Bachelor’s Degree in Medical Science with Hons in 1998 at the University of Sydney and Doctor of Philosophy in Pharmacology in 2003 at the University of Queensland. He completed his post-doctoral training at the Louisiana State University Health Sciences Center in Shreveport, USA in the research laboratory of Professor Neil Granger and at the National Institute of Health, Baltimore, USA in the laboratory of Professor Mark Mattson. He started his independent laboratory at the Texas Tech University Health Sciences Center (TTUHSC) in 2007, and moved to the School of Biomedical Sciences at The University of Queensland (UQ) as a Senior Lecturer, to continue his work researching CNS neurodegeneration and ischaemic stroke. He was awarded the highly competitive UQ Foundation Research Excellence Award in 2011. He also received the Australian Research Council (ARC) Future Fellowship in 2011. He was then appointed as an Associate Professor in the Department of Physiology, Yong Loo Lin School of Medicine at the National University of Singapore in July 2013. Professor Arumugam joined La Trobe University in March 2020.
Professor Arumugam’s major research focuses on unravelling neuronal cell death mechanisms in stroke and vascular dementia. Dr. Arumugam’s research into novel targets for therapy has the very real prospect of both transforming the field, as well as providing an intellectual platform for new drug development.
Professor Arumugam has published over 200 articles extensively in diverse high-impact journals and three book chapters. Among these, articles were published in prestigious journals as first/corresponding/senior author such as Nature Medicine, Circulation, PNAS, Nature Communications, Molecular Psychiatry, Annals Neurology, Cell Metabolism, Theranostics, Progress in Neurobiology, Cell Death & Disease, Ageing Research Reviews, and Human Molecular Genetics. Professor Arumugam has over 23,000 (Google Scholar) career citations. His h-index is 79.
Abstracts this author is presenting: